Replimune Group, Inc. (NASDAQ: REPL - Get Free Report)'s stock price gapped up before the market ope

NEW YORK--(BUSINESS WIRE)---- $REPL #ClassAction--The law firm of Kirby McInerney LLP announces that

SAN DIEGO, Aug. 10, 2026 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP  announces that purchasers

REPL's RP1 secures FDA approval for advanced melanoma, easing regulatory uncertainty. The company ex

SAN DIEGO, Aug. 10, 2026 /PRNewswire/ -- Shareholder rights law firm Robbins LLP informs investors t

BOSTON, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL) (“Replimune”), a comm

[url="]The DJS Law Group[/url] reminds investors of a class action lawsuit against Replimune Group,

LOS ANGELES--(BUSINESS WIRE)---- $REPL--Replimune Group, Inc. Sued for Securities Law Violations - C

LOS ANGELES--(BUSINESS WIRE)---- $REPL--REPL Investors Have Opportunity to Lead Replimune Group, Inc

Law Offices of Howard G. Smith reminds investors of the upcoming October 5, 2026 deadline to file a

[url="]The Law Offices of Frank R. Cruz[/url] reminds investors of the upcoming October 5, 2026 dead

[url="]Glancy Prongay Wolke and Rotter LLP[/url] reminds investors of the upcoming October 5, 2026 d

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming Oct

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming Oct

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming Oc

Replimune secures FDA approval for Tudriqev on its third attempt, making it the company's first prod

NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities cl

ATLANTA, Aug. 07, 2026 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against

[url="]The Law Offices of Frank R. Cruz[/url] announces that a class action lawsuit has been filed o

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit

Replimune Group, Inc. (REPL) Shareholder/Analyst Call Transcript

LOS ANGELES--(BUSINESS WIRE)--Law Offices of Frank R. Cruz Encourages Replimune Group, Inc. (REPL) S

The U.S. Food and Drug Administration (FDA) on Thursday granted accelerated approval to Replimune Gr

Shareholder rights law firm [url="]Robbins LLP[/url] informs investors that a class action was filed

SAN DIEGO--(BUSINESS WIRE)---- $REPL #ReplimuneGroupInc--Robbins LLP is investigating allegations th

NEW YORK, Aug. 6, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors

[url="]Glancy Prongay Wolke and Rotter LLP[/url] (“GPWR”), announces that it has filed a class a

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP (“GPWR”), announces that it has file

The U.S. Food and Drug Administration has approved ​Replimune's drug for a difficult-to-treat form ‌

The agency had turned down two earlier applications over clinical data-quality concerns.

If you purchased or acquired stock in Replimune and would like to discuss your legal rights, contact

The law firm of [url="]Kirby McInerney LLP[/url] reminds investors of its investigation on behalf of

NEW YORK--(BUSINESS WIRE)---- $REPL #classaction--The law firm of Kirby McInerney LLP reminds invest

NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves

Wall Street wasted no time Monday, sending the Nasdaq surging past 25,900 while analysts took aim at

Analysts upgraded Replimune, Madrigal, BBB Foods, Palantir, and Fomento Economico. See other opinion

Gainers Replimune Group (NASDAQ:REPL) stock rose 96.1% to $10.61 during Friday's regular sessio

FDA advisory panel backed Replimune's RP1 melanoma data ahead of the agency's August 2 decis

US stocks rise, Nasdaq up 300 points. Dow up 0.36%, Nasdaq up 1.31%, S&P 500 up 0.65%. Amazon sh

Gainers Replimune Group (NASDAQ:REPL) shares increased by 134.6% to $12.69 during Friday's pre-

Top Wall Street analysts upgraded IP, AXTI, REPL, and PLXS stocks with higher price targets. See wha

AMZN: 13% | Amazon.com shares are trading higher after the company reported better-than-expected Q2

Amazon reported strong Q2 results, beating revenue and earnings estimates. Shares jumped 11.9% in pr

Gainers OPKO Health (NASDAQ:OPK) shares increased by 34.7% to $1.67 during Tuesday's regular se

Gainers Gossamer Bio (NASDAQ:GOSS) shares moved upwards by 47.2% to $0.29 during Tuesday's pre-

Gainers GlucoTrack (NASDAQ:GCTK) stock moved upwards by 28.6% to $0.64 during Thursday's after-

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Capricor stock falls after the FDA schedules a July advisory committee meeting for Deramiocel, its D

Several stocks, including Optimum Communications Services, surged while Dow fell. Technology, energy